Processa Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Processa Pharmaceuticals, Inc.

Processa Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development of drug products for the treatment of patients with unmet medical needs in the United States. Its lead product candidate is PCS499, an oral tablet that…

Biotechnology
US, Hanover [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Processa Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of PCSA's Analysis
CIK: 1533743 CUSIP: 74275C205 ISIN: US74275C3043 LEI: - UEI: -
Secondary Listings
PCSA has no secondary listings inside our databases.